Get the Stockscreener App
9.68
2.81%
-0.28
Immatics N V stock is traded at $9.68, with a volume of 264.07K.
It is down -2.81% in the last 24 hours and up +9.13% over the past month.
Immatics NV is a clinical-stage biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.
See More
Previous Close:
$9.96
Open:
$9.92
24h Volume:
264.07K
Relative Volume:
0.59
Market Cap:
$1.32B
Revenue:
$53.99M
Net Income/Loss:
$-222.30M
P/E Ratio:
-5.3286
EPS:
-1.8166
Net Cash Flow:
$-213.50M
1W Performance:
-2.71%
1M Performance:
+9.13%
6M Performance:
+5.56%
1Y Performance:
+61.33%
1-Day Range:
$9.40
$9.92
1-Week Range:
$9.40
$10.89
52-Week Range:
$5.05
$12.41
Immatics N V Stock (IMTX) Company Profile
Compare IMTX vs VRTX, REGN, ARGX, ALNY, RVMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IMTX
Immatics N V
|
9.68 | 1.32B | 53.99M | -222.30M | -213.50M | -1.8166 |
VRTX
Vertex Pharmaceuticals Inc
|
485.39 | 123.19B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
664.52 | 69.67B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
877.62 | 54.58B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
298.76 | 39.89B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
186.88 | 39.73B | 742.00K | -1.37B | -1.07B | -7.0731 |
Immatics N V Stock (IMTX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-16-26 | Resumed | Jefferies | Buy |
| Sep-18-25 | Initiated | Guggenheim | Buy |
| May-28-25 | Initiated | Deutsche Bank | Buy |
| Oct-07-24 | Initiated | Piper Sandler | Overweight |
| Nov-02-23 | Initiated | Cantor Fitzgerald | Overweight |
| Mar-31-23 | Initiated | Mizuho | Buy |
| Mar-24-23 | Initiated | Bryan Garnier | Buy |
| Nov-20-20 | Initiated | BofA Securities | Buy |
| Sep-22-20 | Initiated | Goldman | Buy |
| Jul-27-20 | Initiated | SVB Leerink | Outperform |
| Jul-24-20 | Initiated | Jefferies | Buy |
View All
Immatics N V Stock (IMTX) Latest News
Immatics stock holds attention. The focus shifts to its pipeline. - ad-hoc-news.de
Responsive Playbooks and the IMTX Inflection - Stock Traders Daily
Immatics N.V. Actuals & Estimates (NASDAQ:IMTX) - TradingView
Enterprise value to revenue forward of Immatics N.V. – NASDAQ:IMTX - TradingView
Price to book forward of Immatics N.V. – NASDAQ:IMTX - TradingView
Enterprise value to EBIT forward of Immatics N.V. – NASDAQ:IMTX - TradingView
Enterprise value to EBIT forward of Immatics N.V. – MUN:4A3 - TradingView
IMTX Forecast — Price Target — Prediction for 2027 - TradingView
Immatics N.V. (IMTX) Q1 2026 Earnings: EPS Miss Reflects Higher R&D Investment; Pipeline Progress Continues - dars.gov.et
Immatics N.V. Actuals & Estimates (TRADEGATE:4A3) - TradingView
Immatics N.V. Actuals & Estimates (FWB:4A3) - TradingView
Immatics NV (IMTXW) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Immatics NV (IMTX) Institutional Confidence - TradingKey
Understanding the Setup: (IMTX) and Scalable Risk - Stock Traders Daily
Immatics Shareholders Approve All Proposals at June 18, 2026 AGM - The Globe and Mail
Immatics (IMTX) director Adam Leo Stone receives 48,000 stock options award - Stock Titan
Immatics (IMTX) awards director Alise Reicin 48,000 stock options - Stock Titan
Immatics (IMTX) director receives grant of 48,000 stock options at $9.09 - Stock Titan
Immatics (IMTX) director receives 48,000 stock options vesting in 2026 - Stock Titan
Immatics N.V. (IMTX) grants director options on 48,000 ordinary shares - Stock Titan
Immatics N.V. (IMTX) director awarded 48,000 stock options at $9.09 - Stock Titan
Immatics (IMTX) director Heather Mason receives 48,000 stock options at $9.09 strike - Stock Titan
48,000 Immatics (IMTX) options tied to board role granted - Stock Titan
Immatics (IMTX) director Mathias Hothum awarded 48,000 options at $9.09 strike - Stock Titan
Immatics N.V. (IMTX) 2026 AGM sees all voting items approved and strong turnout - Stock Titan
Immatics NV (IMTXW) Valuation: PE, PB & Fair Value Analysis - TradingKey
Immatics NV (IMTX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Immatics NV (IMTXW) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Immatics NV (IMTXW) Institutional Confidence - TradingKey
Immatics NV (IMTXW) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Immatics NV (IMTXW) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Immatics NV (IMTX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Immatics NV (IMTX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Immatics NV (IMTXW) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Immatics NV (IMTXW) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Immatics NV (IMTXW) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Immatics NV (IMTX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Immatics NV (IMTX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Immatics NV (IMTX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Immatics NV (IMTX) Valuation: PE, PB & Fair Value Analysis - TradingKey
Immatics NV (IMTX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Immatics: PRAME Is Becoming More Than A Single-Asset Story (NASDAQ:IMTX) - Seeking Alpha
Immatics (IMTX) Reports Q1 Loss, Lags Revenue Estimates - Eastern Progress
How Investors May Respond To Immatics (IMTX) Advancing Its PRAME Franchise With New ASCO 2026 Data - Sahm
TD Cowen initiates coverage of Immatics NV (IMTX) with buy recommendation - MSN
The Technical Signals Behind (IMTX) That Institutions Follow - Stock Traders Daily
IMTX SEC FilingsImmatics N.V 10-K, 10-Q, 8-K Forms - Stock Titan
Immatics NV Stock Hits Day Low of $9.81 Amid Price Pressure - MarketsMojo
Immatics (IMTX) Faces Headwinds as Shares Decline 3.83% Amid Sector RotationStock News - newsline.com
Immatics N.V. (IMTX) Q1 2026 Earnings: Wider-than-Expected Loss Reflects Ongoing Clinical InvestmentNegative Surprise Momentum - newsline.com
Immatics (IMTX) Shows Modest Uptick as Shares Trade Above Key SupportLast Point Support - dars.gov.et
Immatics N V Stock (IMTX) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.64%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):